http://www.unboundmedicine.com/medline/ebm/research/atomoxetineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/20234829/full_citation/Self_esteem_in_adolescent_patients_with_attention_deficit/hyperactivity_disorder_during_open_label_atomoxetine_treatment:_psychometric_evaluation_of_the_Rosenberg_Self_Esteem_Scale_and_clinical_findings_Dittmann RW, Wehmeier PM, Schacht A, et al. 
Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings. [JOURNAL ARTICLE]
Atten Defic Hyperact Disord 2009 Dec; 1(2):187-200.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/20234828/full_citation/Relationship_between_atomoxetine_plasma_concentration_treatment_response_and_tolerability_in_attention_deficit/hyperactivity_disorder_and_comorbid_oppositional_defiant_disorder_Hazell P, Becker K, Nikkanen EA, et al. 
Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. [JOURNAL ARTICLE]
Atten Defic Hyperact Disord 2009 Dec; 1(2):201-210.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20232490/full_citation/Pre_existing_cardiovascular_conditions_and_pharmacological_treatment_of_adult_ADHD_Gerhard T, Winterstein AG, Olfson M, et al. 
Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD. [JOURNAL ARTICLE]
Pharmacoepidemiol Drug Saf 2010 Mar 16.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20178404/full_citation/Pharmacological_treatment_patterns_among_patients_with_attention_deficit/hyperactivity_disorder:_retrospective_claims_based_analysis_of_a_managed_care_population_Christensen L, Sasané R, Hodgkins P, et al. 
Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. [JOURNAL ARTICLE]
Curr Med Res Opin 2010 Feb 23.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20166797/full_citation/Trends_in_incidence_and_characteristics_of_children_adolescents_and_adults_initiating_immediate__or_extended_release_methylphenidate_or_atomoxetine_in_the_Netherlands_during_2001_2006_van den Ban E, Souverein P, Swaab H, et al. 
Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006. [Journal Article]
J Child Adolesc Psychopharmacol 2010 Feb; 20(1):55-61.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/20156489/full_citation/PREPUBERAL_SUBCHRONIC_METHYLPHENIDATE_AND_ATOMOXETINE_INDUCE_DIFFERENT_LONG_TERM_EFFECTS_ON_ADULT_BEHAVIOUR_AND_FOREBRAIN_DOPAMINE_NOREPINEPHRINE_AND_SEROTONIN_IN_NAPLES_HIGH_EXCITABILITY_RATS_Ruocco LA, Carnevale UA, Treno C, et al. 
PREPUBERAL SUBCHRONIC METHYLPHENIDATE AND ATOMOXETINE INDUCE DIFFERENT LONG-TERM EFFECTS ON ADULT BEHAVIOUR AND FOREBRAIN DOPAMINE, NOREPINEPHRINE AND SEROTONIN IN NAPLES HIGH-EXCITABILITY RATS. [JOURNAL ARTICLE]
Behav Brain Res 2010 Feb 12.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20094643/full_citation/Gateways_to_clinical_trials_Tomillero A, Moral MA 
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Nov; 31(9):597-633.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20088618/full_citation/Progress_and_promise_of_attention_deficit_hyperactivity_disorder_pharmacogenetics_Froehlich TE, McGough JJ, Stein MA 
Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics. [Journal Article]
CNS Drugs 2010 Feb 1; 24(2):99-117.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/20078461/full_citation/Cognitive_enhancement_as_a_pharmacotherapy_target_for_stimulant_addiction_Sofuoglu M 
Cognitive enhancement as a pharmacotherapy target for stimulant addiction. [JOURNAL ARTICLE]
Addiction 2010 Jan; 105(1):38-48.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/20070786/full_citation/Atomoxetine_in_the_treatment_of_adults_with_subthreshold_and/or_late_onset_attention_deficit_hyperactivity_disorder_not_otherwise_specified__ADHD_NOS_:_a_prospective_open_label_6_week_study_Surman C, Hammerness P, Petty C, et al. 
Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): a prospective open-label 6-week study. [Journal Article]
CNS Neurosci Ther 2010; 16(1):6-12.
Abstract | Full Citation | Find Related Articles